disc-3405
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 3, 2023 (NCT06050915)
Timeline
Indications
Mechanism of action
- Transmembrane protease serine 6INHIBITOR
TMPRSS6 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07187973 | Phase 1 | Oct 31, 2025 | Disc Medicine, Inc |
| NCT06985147 | Phase 2 | Aug 12, 2025 | Disc Medicine, Inc |
| NCT06050915 | Phase 1 | Oct 3, 2023 | Disc Medicine, Inc |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Disc Medicine, Inc | For profit | 3 | 3 | 2 | 2023 |
1 organizations
Page 1 / 1